The U.S. Food and Drug Administration (USFDA) is inspecting Dr. Reddy’s analysis and improvement centre in Hyderabad, the pharma firm mentioned on Tuesday.
“We confirm the commencement of a USFDA inspection at our R&D centre,” a Reddy’s spokesperson mentioned.
A unit of Laurus Labs’ subsidiary Laurus Synthesis in Visakhapatnam, Andhra Pradesh can also be being inspected by the U.S. drug regulator, in accordance with a supply accustomed to the matter.
Rivals Sun Pharma’s Dadra facility and Torrent Pharmaceuticals Ltd.’s oncology unit are additionally present process FDA inspections, in accordance with media studies.
Sun Pharma, Laurus and Torrent didn’t instantly reply to Reuters’ requests in search of remark.
